Memphis Oxbryta Lawyer

What Is Oxbryta and Why Is It Dangerous?

Oxbryta is part of a class of medications called hemoglobin S polymerization inhibitors designed to treat sickle cell disease (SCD), a genetic blood disorder affecting approximately 100,000 Americans, with higher prevalence among African Americans. The medication’s mechanism involves increasing hemoglobin’s oxygen affinity, theoretically preventing red blood cells from sickling and improving blood flow.

While the drug initially showed promise in clinical trials, post-approval investigation has revealed alarming safety concerns. The FDA’s adverse event reporting system has documented numerous cases of patients experiencing severe complications after starting Oxbryta therapy.

The most concerning finding involves an increased frequency of vaso-occlusive crises (VOCs), which are excruciatingly painful episodes when sickled cells obstruct blood vessels and prevent oxygen delivery to tissues. Contrary to its intended purpose, evidence suggests Oxbryta may actually trigger these crises in some patients, leading to emergency hospitalization.

Do You Qualify for an Oxbryta Lawsuit?

Tennessee residents who took Oxbryta for sickle cell disease and subsequently experienced serious health complications may qualify for significant compensation. Gatti, Keltner, Bienvenu & Montesi is currently evaluating cases that meet specific criteria to determine eligibility for legal action.

Key qualifying factors include:

• Confirmed Medication Use: Documentation showing you were prescribed and took Oxbryta (voxelotor) for sickle cell disease treatment.
• Serious Health Complications: Development of one or more severe side effects after beginning treatment, such as:
  • Vaso-occlusive crises requiring emergency care
  • Acute pain episodes necessitating hospitalization
  • Stroke
  • Kidney damage
  • Severe arthritis
  • Other significant adverse reactions
• Medical Documentation: Healthcare records linking your complications to Oxbryta use, potentially including a doctor’s recommendation to discontinue the medication due to safety concerns.
• Temporal Connection: Clear timeline showing complications occurred while taking Oxbryta or within a reasonable period after stopping the medication.